牛叉诊股

[{"date":"2026.04.14","stock":"1.07","trade":"0.68","ind":"1.61"},{"date":"2026.04.13","stock":"-0.38","trade":"-0.85","ind":"0.69"},{"date":"2026.04.10","stock":"-0.44","trade":"0.52","ind":"2.24"},{"date":"2026.04.09","stock":"-1.48","trade":"-2.18","ind":"-0.33"},{"date":"2026.04.08","stock":"0.75","trade":"1.06","ind":"4.79"},{"date":"2026.04.07","stock":"-1.95","trade":"0.46","ind":"0.36"},{"date":"2026.04.03","stock":"-3.13","trade":"-2.72","ind":"-0.99"},{"date":"2026.04.02","stock":"0.18","trade":"1.12","ind":"-1.60"},{"date":"2026.04.01","stock":"7.63","trade":"4.62","ind":"1.70"},{"date":"2026.03.31","stock":"0.38","trade":"-0.68","ind":"-1.81"},{"date":"2026.03.30","stock":"1.16","trade":"0.96","ind":"-0.25"},{"date":"2026.03.27","stock":"6.61","trade":"4.54","ind":"1.13"},{"date":"2026.03.26","stock":"-1.22","trade":"-0.58","ind":"-1.41"},{"date":"2026.03.25","stock":"0.14","trade":"1.24","ind":"1.95"},{"date":"2026.03.24","stock":"1.94","trade":"4.01","ind":"1.43"},{"date":"2026.03.23","stock":"-4.76","trade":"-5.71","ind":"-3.76"},{"date":"2026.03.20","stock":"-3.82","trade":"-2.21","ind":"-0.25"},{"date":"2026.03.19","stock":"-3.62","trade":"-2.44","ind":"-2.02"},{"date":"2026.03.18","stock":"-0.91","trade":"0.78","ind":"1.05"},{"date":"2026.03.17","stock":"0.67","trade":"-0.82","ind":"-1.87"},{"date":"2026.03.16","stock":"1.62","trade":"0.60","ind":"0.19"}]

京新药业,深证成指,化学制药指数

压力支撑

该股压力位为15.89元，支撑位为15.70元。

[{"text":"\u538b\u529b\u4f4d","value":"15.89","date":1776096000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.70","date":1776096000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.0资金面打败了3%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：04月14日 20:30

机构今日流向(万元)	-522.98	机构5日流向(万元)	-8340.94
机构10日流向(万元)	-8212.91	机构20日流向(万元)	-10601.95

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少9101.73万股，其中基金净减仓19家，主力净增仓114家，暂未发现中长期投资价值。

截止2025-12-31，共277家主力机构（基金277家），持仓量总计10625.28万股，占流通A股14.68%
其中，基金持仓与2025-06-30相比：
增仓：21家，增持 159.98万股
减仓：40家，减持 474.95万股
新出现在主力名单中：204家，持有8339.18万股
从主力名单中消失：90家，原持有17125.94万股

消息面诊股

诊断结果：5.5消息面打败了21%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-01-13
一般消息	高管变动	取消监事会	2025-10-10
一般消息	分红转增	不分配不转增	2025-08-27

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	0条	0条	0条

行业面诊股

诊断结果：6.3行业面打败了82%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.14","price":"1.61","value":"0.68"},{"date":"2026.04.13","price":"0.69","value":"-0.85"},{"date":"2026.04.10","price":"2.24","value":"0.52"},{"date":"2026.04.09","price":"-0.33","value":"-2.18"},{"date":"2026.04.08","price":"4.79","value":"1.06"},{"date":"2026.04.07","price":"0.36","value":"0.46"},{"date":"2026.04.03","price":"-0.99","value":"-2.72"},{"date":"2026.04.02","price":"-1.60","value":"1.12"},{"date":"2026.04.01","price":"1.70","value":"4.62"},{"date":"2026.03.31","price":"-1.81","value":"-0.68"},{"date":"2026.03.30","price":"-0.25","value":"0.96"},{"date":"2026.03.27","price":"1.13","value":"4.54"},{"date":"2026.03.26","price":"-1.41","value":"-0.58"},{"date":"2026.03.25","price":"1.95","value":"1.24"},{"date":"2026.03.24","price":"1.43","value":"4.01"},{"date":"2026.03.23","price":"-3.76","value":"-5.71"},{"date":"2026.03.20","price":"-0.25","value":"-2.21"},{"date":"2026.03.19","price":"-2.02","value":"-2.44"},{"date":"2026.03.18","price":"1.05","value":"0.78"},{"date":"2026.03.17","price":"-1.87","value":"-0.82"},{"date":"2026.03.16","price":"0.19","value":"0.60"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	美诺华	102.79%	29.64%	6.0分
2	津药药业	47.74%	-18.90%	5.9分
3	ST景峰	41.39%	2.15%	4.9分
4	华纳药厂	32.96%	-6.61%	5.5分
5	富祥药业	24.19%	4.46%	4.7分
6	莱美药业	23.35%	2.66%	5.4分
7	舒泰神	22.72%	3.51%	5.4分
8	纳微科技	20.21%	24.77%	5.9分
9	泽璟制药	20.04%	-1.51%	5.4分
10	海思科	19.66%	4.77%	6.4分
11	双鹭药业	18.96%	-14.65%	4.1分
12	迪哲医药	17.58%	3.41%	6.1分
13	翰宇药业	17.51%	8.77%	6.1分
14	海森药业	14.13%	2.32%	5.5分
15	宏源药业	13.56%	10.03%	5.9分
16	*ST赛隆	13.11%	3.64%	5.0分
17	哈药股份	12.85%	4.39%	6.2分
18	百利天恒	12.75%	-3.19%	5.9分
19	信立泰	12.38%	-4.16%	5.5分
20	司太立	12.26%	5.38%	5.7分
21	苑东生物	11.98%	-15.48%	5.5分
22	誉衡药业	10.45%	-0.80%	5.9分
23	汇宇制药	10.02%	-19.50%	5.4分
24	海创药业	9.77%	5.87%	6.0分
25	亚太药业	9.57%	-7.80%	4.6分
26	一品红	9.10%	-1.17%	5.3分
27	益方生物	8.29%	-4.55%	5.4分
28	奥赛康	8.02%	0.00%	5.3分
29	奥翔药业	7.46%	3.08%	5.5分
30	常山药业	6.91%	5.90%	4.7分
31	东诚药业	6.68%	-1.59%	5.1分
32	罗欣药业	6.61%	0.98%	6.1分
33	通化金马	5.21%	5.71%	4.9分
34	科伦药业	5.02%	-0.15%	5.2分
35	首药控股	4.85%	2.38%	5.5分
36	金城医药	4.77%	8.97%	6.4分
37	赛分科技	4.69%	4.26%	6.9分
38	百济神州	4.66%	2.09%	5.4分
39	联环药业	4.45%	-10.74%	4.8分
40	力生制药	4.43%	-0.93%	5.4分
41	吉贝尔	4.28%	0.32%	5.7分
42	前沿生物	3.92%	0.45%	4.6分
43	复星医药	3.32%	-0.82%	5.1分
44	盟科药业	3.32%	-1.42%	5.0分
45	千红制药	3.30%	0.26%	5.1分
46	天宇股份	3.20%	2.65%	5.5分
47	新和成	2.33%	0.24%	6.0分
48	广生堂	2.30%	-2.23%	5.1分
49	上海谊众	2.06%	-3.96%	5.5分
50	博瑞医药	2.04%	-5.84%	4.4分
51	艾力斯	1.99%	1.33%	5.7分
52	悦康药业	1.93%	0.21%	5.4分
53	中关村	1.73%	0.19%	6.0分
54	贝达药业	1.65%	0.88%	5.1分
55	华海药业	1.64%	1.45%	5.0分
56	北大医药	1.49%	-11.00%	5.1分
57	金陵药业	1.35%	-7.28%	5.5分
58	-	1.34%	-12.12%	分
59	*ST三圣	1.08%	6.12%	5.4分
60	恒瑞医药	1.06%	0.11%	6.4分
61	诚意药业	0.84%	-0.67%	5.7分
62	泰恩康	0.43%	2.87%	5.0分
63	奥锐特	0.34%	-6.37%	5.3分
64	*ST惠程	0.24%	2.72%	5.5分
65	灵康药业	0.00%	-8.80%	5.4分
66	昂利康	-0.07%	-9.77%	4.8分
67	微芯生物	-0.13%	3.21%	5.9分
68	键凯科技	-0.18%	7.49%	6.8分
69	东北制药	-0.19%	-3.09%	5.2分
70	华润双鹤	-0.22%	-1.25%	5.3分
71	海普瑞	-0.26%	-0.44%	5.9分
72	共同药业	-0.75%	-2.30%	5.1分
73	海翔药业	-0.83%	2.56%	5.8分
74	立方制药	-0.86%	-1.51%	5.6分
75	福元医药	-0.86%	-1.63%	6.0分
76	同和药业	-0.98%	-0.86%	5.4分
77	福安药业	-1.17%	-1.17%	4.8分
78	金石亚药	-1.26%	-1.55%	5.6分
79	圣诺生物	-1.26%	3.07%	5.7分
80	华东医药	-1.33%	-2.62%	5.3分
81	北陆药业	-1.33%	2.76%	5.8分
82	神奇制药	-1.41%	-5.14%	6.3分
83	尔康制药	-1.48%	1.27%	4.4分
84	恩华药业	-1.63%	0.49%	5.1分
85	新诺威	-1.69%	-5.38%	5.0分
86	仙琚制药	-1.86%	-1.43%	4.8分
87	丰原药业	-1.94%	-5.20%	5.4分
88	健康元	-1.96%	-1.52%	5.4分
89	京新药业	-2.02%	-0.50%	5.3分
90	亨迪药业	-2.03%	-1.55%	5.5分
91	威尔药业	-2.38%	-0.16%	5.9分
92	海辰药业	-2.45%	-0.86%	4.5分
93	华北制药	-2.47%	-1.95%	5.4分
94	仟源医药	-2.49%	3.25%	5.8分
95	海正药业	-2.54%	-2.73%	5.5分
96	兴齐眼药	-2.58%	4.16%	6.0分
97	华仁药业	-2.73%	-5.87%	6.2分
98	ST诺泰	-2.83%	7.43%	5.2分
99	丽珠集团	-2.90%	-0.88%	5.3分
100	拓新药业	-2.90%	-1.65%	4.1分
101	-	-2.93%	0.64%	分
102	-	-3.00%	1.21%	分
103	小方制药	-3.14%	-0.44%	4.8分
104	西点药业	-3.15%	-5.96%	5.4分
105	复旦张江	-3.30%	-0.75%	4.8分
106	普洛药业	-3.53%	-1.07%	5.4分
107	健友股份	-3.68%	0.10%	5.5分
108	哈三联	-3.83%	-6.48%	4.0分
109	宣泰医药	-4.06%	-2.58%	5.2分
110	亚虹医药	-4.07%	1.87%	5.5分
111	-	-4.15%	4.52%	分
112	ST人福	-4.24%	-0.05%	5.4分
113	山河药辅	-4.25%	-1.94%	5.9分
114	天新药业	-4.33%	-0.92%	5.5分
115	德展健康	-4.46%	-2.83%	3.8分
116	永安药业	-4.50%	-0.50%	4.8分
117	新华制药	-4.55%	-1.68%	4.9分
118	辰欣药业	-4.59%	-0.73%	4.5分
119	海南海药	-4.63%	-0.74%	4.6分
120	民生健康	-4.67%	-0.85%	4.7分
121	-	-4.75%	1.82%	分
122	卫信康	-4.93%	-3.61%	5.6分
123	九典制药	-5.02%	-1.89%	4.5分
124	新天地	-5.18%	-2.70%	5.4分
125	ST天圣	-5.39%	1.39%	5.2分
126	必贝特	-5.70%	-2.00%	5.5分
127	赛托生物	-5.71%	-1.46%	5.4分
128	莎普爱思	-5.87%	-3.58%	4.9分
129	南新制药	-5.87%	-4.56%	4.2分
130	鲁抗医药	-6.11%	-1.31%	4.6分
131	本立科技	-6.44%	1.05%	5.9分
132	海欣股份	-6.67%	0.00%	6.2分
133	-	-6.79%	-1.73%	分
134	易明医药	-6.96%	0.75%	6.0分
135	汉商集团	-7.01%	-2.56%	5.3分
136	华邦健康	-7.05%	-2.10%	4.6分
137	富士莱	-7.33%	-0.37%	5.6分
138	华特达因	-7.38%	0.10%	4.9分
139	-	-7.63%	0.45%	分
140	向日葵	-8.35%	-0.75%	4.1分
141	浙江医药	-8.58%	-4.28%	5.0分
142	-	-8.67%	-0.58%	分
143	广济药业	-9.17%	-5.46%	5.3分
144	国药现代	-9.67%	-6.66%	5.4分
145	河化股份	-9.77%	-3.30%	4.9分
146	-	-10.02%	-9.14%	分
147	ST复华	-10.72%	0.88%	4.3分
148	川宁生物	-10.81%	-1.43%	4.5分
149	东亚药业	-11.59%	-3.68%	4.8分
150	溢多利	-11.67%	-1.40%	4.6分
151	国邦医药	-11.92%	0.20%	5.9分
152	花园生物	-12.06%	0.07%	5.0分
153	亿帆医药	-13.55%	-4.40%	4.7分
154	康芝药业	-14.25%	-13.86%	3.9分
155	润都股份	-16.70%	-8.95%	4.9分
156	能特科技	-18.89%	-4.89%	4.6分
157	多瑞医药	-19.66%	6.64%	5.1分
158	科源制药	-24.80%	7.94%	4.9分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.9基本面打败了88%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（82.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 26/219 ， 72/219。

[{"date":"2025-09-30","value":"9.91","vol":"1.50"},{"date":"2025-06-30","value":"6.79","vol":"1.22"},{"date":"2025-03-31","value":"2.80","vol":"-0.14"},{"date":"2024-12-31","value":"12.40","vol":"19.49"},{"date":"2024-09-30","value":"10.14","vol":"4.59"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	9.91	6.79	2.80	12.40	10.14
行业(%)	1.50	1.22	-0.14	19.49	4.59

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"50.07","vol":"49.37"},{"date":"2025-06-30","value":"49.57","vol":"49.34"},{"date":"2025-03-31","value":"47.71","vol":"49.16"},{"date":"2024-12-31","value":"49.97","vol":"50.51"},{"date":"2024-09-30","value":"51.11","vol":"50.38"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	50.07	49.57	47.71	49.97	51.11
行业(%)	49.37	49.34	49.16	50.51	50.38

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 87/219 ， 76/219。

[{"date":"2025-09-30","value":"-5.00","vol":"142.64"},{"date":"2025-06-30","value":"-6.20","vol":"79.13"},{"date":"2025-03-31","value":"-9.86","vol":"-0.03"},{"date":"2024-12-31","value":"3.99","vol":"17.80"},{"date":"2024-09-30","value":"9.68","vol":"45.67"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-5.00	-6.20	-9.86	3.99	9.68
行业(%)	142.64	79.13	-0.03	17.80	45.67

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.10","vol":"-2.91"},{"date":"2025-06-30","value":"-3.54","vol":"58.54"},{"date":"2025-03-31","value":"-4.62","vol":"-10.77"},{"date":"2024-12-31","value":"15.04","vol":"-75.44"},{"date":"2024-09-30","value":"21.66","vol":"-34.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	0.10	-3.54	-4.62	15.04	21.66
行业(%)	-2.91	58.54	-10.77	-75.44	-34.88

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 43/219 ， 58/219。

[{"date":"2025-09-30","value":"0.37","vol":"0.31"},{"date":"2025-06-30","value":"0.25","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.51","vol":"0.43"},{"date":"2024-09-30","value":"0.39","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.37	0.25	0.12	0.51	0.39
行业(次)	0.31	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.93","vol":"1.94"},{"date":"2025-06-30","value":"1.25","vol":"1.30"},{"date":"2025-03-31","value":"0.62","vol":"0.66"},{"date":"2024-12-31","value":"2.88","vol":"3.18"},{"date":"2024-09-30","value":"2.22","vol":"2.12"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.93	1.25	0.62	2.88	2.22
行业(次)	1.94	1.30	0.66	3.18	2.12

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"21.57","vol":"4.25"},{"date":"2025-06-30","value":"21.69","vol":"2.97"},{"date":"2025-03-31","value":"17.04","vol":"-26.71"},{"date":"2024-12-31","value":"11.95","vol":"-371.76"},{"date":"2024-09-30","value":"12.89","vol":"-10.28"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	21.57	21.69	17.04	11.95	12.89
行业	4.25	2.97	-26.71	-371.76	-10.28

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.71","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.81","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.71	-	0.81	-
行业	0.00	1.71	0.00	1.99	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 26/219 ， 18/219。

[{"date":"2025-09-30","value":"1.62","vol":"3.48"},{"date":"2025-06-30","value":"1.36","vol":"3.67"},{"date":"2025-03-31","value":"1.42","vol":"3.59"},{"date":"2024-12-31","value":"1.36","vol":"3.34"},{"date":"2024-09-30","value":"1.23","vol":"3.65"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.62	1.36	1.42	1.36	1.23
行业	3.48	3.67	3.59	3.34	3.65

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.83","vol":"2.73"},{"date":"2025-06-30","value":"0.70","vol":"2.88"},{"date":"2025-03-31","value":"0.79","vol":"2.81"},{"date":"2024-12-31","value":"0.96","vol":"2.63"},{"date":"2024-09-30","value":"0.87","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	0.83	0.70	0.79	0.96	0.87
行业	2.73	2.88	2.81	2.63	2.91

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 69/219 ， 75/219。

[{"date":"2025-09-30","value":"28.74","vol":"34.03"},{"date":"2025-06-30","value":"30.53","vol":"34.15"},{"date":"2025-03-31","value":"28.33","vol":"34.38"},{"date":"2024-12-31","value":"29.22","vol":"34.54"},{"date":"2024-09-30","value":"31.73","vol":"33.36"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	28.74	30.53	28.33	29.22	31.73
行业(%)	34.03	34.15	34.38	34.54	33.36

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.41","vol":"1.19"},{"date":"2025-06-30","value":"0.44","vol":"0.88"},{"date":"2025-03-31","value":"0.40","vol":"1.46"},{"date":"2024-12-31","value":"0.42","vol":"0.83"},{"date":"2024-09-30","value":"0.47","vol":"0.72"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.41	0.44	0.40	0.42	0.47
行业(%)	1.19	0.88	1.46	0.83	0.72

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
中泰证券	2026-02-11	增持

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"6.14","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"6.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.19","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.12","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.95","blueLineValue":"0.92","type":"YC"}]

[京新药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]